Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2014 Nov 26;7(2):240–244. doi: 10.1002/cctc.201402891

Hydrofluorination of Alkynes Catalysed by Gold Bifluorides

Fady Nahra [a], Scott R Patrick [a], Davide Bello [a], Marcel Brill [a], Alan Obled [a], David B Cordes [a], Alexandra M Z Slawin [a], David O'Hagan [a], Steven P Nolan [a],*
PMCID: PMC4515107  PMID: 26236406

Abstract

We report the synthesis of nine new N-heterocyclic carbene gold bifluoride complexes starting from the corresponding N-heterocyclic carbene gold hydroxides. A new methodology to access N,N′-bis(2,6-diisopropylphenyl)imidazol-2-ylidene gold(I) fluoride starting from N,N′-bis(2,6-diisopropylphenyl)imidazol-2-ylidene gold(I) hydroxide and readily available potassium bifluoride is also reported. These gold bifluorides were shown to be efficient catalysts in the hydrofluorination of symmetrical and unsymmetrical alkynes, thus affording fluorinated stilbene analogues and fluorovinyl thioethers in good to excellent yields with high stereo- and regioselectivity. The method is exploited further to access a fluorinated combretastatin analogue selectively in two steps starting from commercially available reagents.

Keywords: alkynes, bifluorides, gold, hydrofluorination, carbenes


Fluorinated organic compounds are highly important in the pharmaceutical and agrochemical industries.[1] Incorporating a fluorinated group into drug-like compounds or biologically active molecules can improve many of their properties, including solubility, bioavailability, and metabolic stability.[2] The number of reports describing such chemistry has increased drastically over the last few years, giving rise to numerous procedures[39] catalysed mainly by Cu,[3] Pd,[4] Ir,[5] Ag,[6] Rh[7] and Mn[8] complexes.

The pioneering work of Sadighi, Gray and co-workers on the Au-catalysed hydrofluorination of alkynes revealed a new pathway for the easy formation of C=F bonds and, subsequently, the immense potential of N-heterocyclic carbene (NHC) gold(I) complexes in this field.[10]

Following reports by Riant, Leyssens and co-workers[11] and more recently by Huang, Weng and co-workers[12] on the high stability and reactivity of copper bifluoride complexes compared to their fluoride analogues, we became intrigued by the possibility of applying this methodology to NHC gold(I) complexes. Even though late transition metal bifluoride complexes have been known for over three decades,[1115] the use of late transition metal bifluorides is still underdeveloped. Most reported complexes are phosphine or amine-based with only two examples bearing a NHC by Riant, Leyssens and co-workers[11] (Cu) and more recently by Whittlesey and co-workers (Rh).[15] We now report on the synthesis of new NHC gold(I) bifluoride complexes and their subsequent role in enabling the hydrofluorination of a range of alkynes.

Strategies consisting of late transition metal tert-butoxide complexes and triethylamine trihydrofluoride (NEt33 HF) proved unreliable when applied to NHC gold(I) complexes, due mainly to the poor stability of the [Au(NHC)(OtBu)] complexes. Previously, we have reported on the synthesis of [Au(IPr)(OH)] (1).[16] We proposed that 1 could be a viable alternative to gold tert-butoxide complexes, thus permitting access to a wide variety of gold bifluoride complexes. Preliminary results proved encouraging, affording exclusively the cationic [[Au(IPr)(NEt3)](HF2)] complex (2 a, Scheme 1). Notably, during our initial optimisations, the gold fluoride complex 3 was always observed but its formation was suppressed subsequently by controlling the amount and dilution of NEt33 HF.

Scheme 1.

Scheme 1

Initial synthetic route to complex 2 a.

The reaction was extended to various N,N′-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (IPr)-based NHCs, whereby six new bifluoride complexes (2 af) were isolated in good yields and characterised fully (Scheme 2). Furthermore, the reaction was effectively scaled to 1 g for the IPr-bearing complex 2 a.

Scheme 2.

Scheme 2

Synthesis of [[Au(NHC)(NEt3)](HF2)] complexes 2 a–f.

In an attempt to exchange the triethylamine moiety for other ligands, we found that the former could be substituted by pyridine by two methods (Scheme 3): reacting [Au(NHC)OH] either with diluted pyridine hydrofluoride (PyHF; method A) or NEt33 HF in the presence of 1 equivalent of pyridine (method B) readily afforded the desired [[Au(NHC)(Py)](HF2)] complexes 4 a,b. Method B was particularly interesting as it allowed for other ligands to be used. This strategy was exploited further by using Se(IPr) as ligand,[17] thus affording the desired cationic complex 5 in good yield. To the best of our knowledge, complex 5 constitutes the first example of a Se-based bifluoride.

Scheme 3.

Scheme 3

Synthesis of [[Au(NHC)(L)](HF2)] complexes and X-ray crystal structure of 4 a. All hydrogen atoms are omitted for clarity (see the Supporting Information for the disorder found for the HF2 anion).

All gold bifluorides were air and moisture-stable in the solid state, and may be considered an anhydrous source of fluoride. More importantly, these species were also highly stable in solution if stored in plastic vials. The 19F NMR signal of these bifluorides showed a broad singlet at approximately −170 ppm, characteristic of a symmetric FHF anion.[11] The acidic proton of the HF2 moiety for complexes 2 ad was observed in CD2Cl2, whereas the remaining bifluorides only revealed this proton in CD3CN.[18a] In all cases, the proton resonated between 13.2 and 13.7 ppm, which is consistent with the structure of these complexes.[11a] Single crystals of 4 a and 5 were grown and X-ray analysis confirmed their structure (see the Supporting Information).[18b]

In an attempt to selectively form the gold monofluoride species, 1 and NEt33 HF (0.33 equiv) were reacted in benzene[10] and a mixture of mono- and bifluoride complexes were obtained in a 70:30 ratio. However, when the [Au(IPr)(OtAm)][16] (6; Am=amyl) complex was reacted under the same conditions, only the gold monofluoride was observed.[19] Therefore, we reasoned that these two species might be in equilibrium and the presence of H2O as a by-product (from the gold hydroxide reaction) was sufficient to shift the equilibrium towards the bifluoride. This phenomenon could be especially important for catalytic fluorination or fluorination and ring-opening processes, in which catalysts, particularly metal fluorides, are exposed to an excess of a HF source.[3a,5b,7,10a]

To examine the persistence of the bifluoride moiety in the presence of a base, [[Au(IPr)(NEt3)](HF2)] (2 a) was reacted with a stoichiometric amount of KOtBu. Full conversion to the corresponding monofluoride (3) was observed within 4 h. Moreover, addition of diluted NEt33 HF (NEt32 HF) to 3 rapidly regenerated the metal bifluoride (2 a).[20] Hence, these two species were found to be inherently linked (Scheme 4) and in the presence of an excess of NEt33 HF or residual H2O, a metal fluoride or hydroxide would more than likely have delivered the metal bifluoride in situ. This might have implications for the future design and development of transition metal-catalysed fluorination methodologies.

Scheme 4.

Scheme 4

Gold fluoride versus gold bifluoride species.

We next reasoned that if KOR was able to deprotonate the gold bifluoride species, the reverse procedure using gold hydroxide species and KHF2 could be possible, thus affording the desired gold fluoride complexes. Gratifyingly, [Au(IPr)OH] complex (1 a) was able to deprotonate inexpensive and readily available KHF2 and deliver the desired [Au(IPr)F] (3) in 81 % yield (Scheme 4).

The newly prepared gold bifluoride complexes were then tested in the catalytic hydrofluorination of alkynes as convenient and air-stable alternatives to the previously described gold catalysts.[10,21] The initial optimisation reactions were performed by using diphenylacetylene (7 a) as a model substrate. After an extensive optimisation, complexes bearing bulkier ligands IPr* (2 e) and IPr*Tol (2 f) proved most effective (see the Supporting Information). The use of a Py or Se moiety instead of NEt3 gave poorer results, which could be explained by their stronger coordination to the gold centre. The final optimal conditions comprised the use of complexes 2 e or 2 f in CH2Cl2 at 50 °C in a sealed plastic vial. The use of the NEt33 HF (3 equiv)/NH4BF4 (1.5 equiv) system allowed for lower catalyst loadings and shorter reaction times (see the Supporting Information, Tables 1–4).

The optimised conditions were then applied to various symmetrical alkynes (Scheme 5). Generally, excellent isolated yields were obtained for 8 ai with a wide range of substitution patterns. The reaction conditions tolerated bulky groups and electron-withdrawing and donating groups in meta and para positions. However, the use of ortho-substituted alkynes led to no reactivity, presumably for steric reasons. Notably, in each case only the Z isomer was afforded, with no E isomer observed. The use of unsymmetrical alkynes was then examined (Scheme 6). In addition to stereoselectivity issues, these substrates also introduced a regioselectivity challenge, thus four different products could be obtained. Early test reactions showed that only the Z isomers were obtained. However, elevated temperatures eroded the regioselectivity and traces of the minor Z isomer were observed by 19F NMR. Therefore, the reactions were performed at room temperature and the lower reactivity was offset by increasing the reaction time to 5 days. This procedure allowed expedient access to compounds that were otherwise extremely difficult to generate. Catalyst 6 f was also employed, as preliminary reactions had shown it to lead to improved selectivities. The method differentiated quite selectively between alkyl and aryl groups (10 ab) and only one isomer was obtained, even if the alkyl group was a benzyl moiety (10 e). More interestingly, substrates 9 c and 9 d allowed for the 1,4-addition of fluoride and the desired products were obtained with high selectivity. The formation of enone 10 c was the only reaction without complete regioselectivity, but the selectivity was still high (especially for this class of substrates) and the major product could be isolated straightforwardly. Finally, 9 f also afforded the desired product 10 f in high yield and selectivity. To the best of our knowledge, this last example constitutes the first of this class of substrates to be catalytically hydrofluorinated in an efficient and selective manner.[22]

Scheme 5.

Scheme 5

Hydrofluorination of symmetrical alkynes. Reaction conditions: alkynes 7 a–i (0.5 mmol), 2 e (2 mol %), NEt3⋅3 HF (1.5 mmol, 3 equiv), NH4BF4 (0.75 mmol, 1.5 equiv) in CH2Cl2 (0.7 m) at 50 °C. [a] t=48 h; [b] 4 mol % of 2 e used.

Scheme 6.

Scheme 6

Hydrofluorination of unsymmetrical alkynes. Reaction conditions: alkynes 9 a–f (0.5 mmol), 2 f (2 mol %), NEt3⋅3 HF (1.5 mmol, 3 equiv), NH4BF4 (0.75 mmol, 1.5 equiv) in CH2Cl2 (0.7 m) at RT.

To fully exploit this strategy, we applied these reaction conditions to a highly functionalised unsymmetrical alkyne. Alkyne 9 g was synthesised by using a modified literature procedure[23] and employed to prepare a fluorinated combretastatin analogue (Scheme 7).[24] Gratifyingly, 40 % conversion to the desired product 10 g was observed with high regioselectivity and stereoselectivity (Scheme 7). Only the major regioisomer was isolated in 32 % yield,[25] characterised fully and its correct structure determined (shown in Scheme 7). This non-optimised procedure is the subject of an on-going investigation in our group.

Scheme 7.

Scheme 7

Synthesis and hydrofluorination of alkyne 9 g. Reaction conditions: alkyne 9 g (0.5 mmol), 2 f (2 mol %), NEt3⋅3 HF (1.5 mmol, 3 equiv), NH4BF4 (0.75 mmol, 1.5 equiv) in CH2Cl2 (0.7 m) at RT. [a] Corrected isolated yield.[25]

We were also interested in the hydrofluorination of alkynyl sulfides 11 to afford fluorovinyl thioethers 12. The latter are considered putative biomimetic surrogates for the enol(ate) of thioesters.[26] Attempts to hydrofluorinate these substrates by using a range of literature procedures[10a,21ab] proved unsuccessful and our alternative protocol was subsequently tested on this substrate class (Scheme 8). Reactions were performed at room temperature until complete consumption of the starting material was observed.[27] Gratifyingly, the desired products 12 ac were obtained in good yields and excellent stereoselectivities. Interestingly, the stereoselectivity proved independent of reaction conditions; the fluorine addition occurred α or β to the sulfur if terminal (11 ab) or internal (11 c) sulfides were used, respectively.

Scheme 8.

Scheme 8

Access to fluorovinyl thioethers through hydrofluorination. Reaction conditions: 12 a–c (0.5 mmol), 2 f (2 mol %), NEt3⋅3 HF (1.5 mmol, 3 equiv) in CH2Cl2 (0.7 m) at RT.

In conclusion, nine novel N-heterocyclic carbene gold bifluoride complexes have been prepared from the corresponding gold(I) hydroxides. The methodology is high yielding, reproducible and scalable. Most importantly, these complexes are highly stable to air and moisture and are thus proposed as practical surrogates for the sensitive gold(I) fluorides. A new methodology to access gold(I) fluorides by using inexpensive and benign potassium bifluoride has been developed. The gold(I) fluorides and bifluorides are shown to be in equilibrium and, as a function of reaction conditions, these two species can readily interconvert. The gold(I) bifluorides have proven to be efficient catalysts in the hydrofluorination of symmetrical and unsymmetrical alkynes, thus affording fluorinated stilbene analogues and fluorovinyl thioethers in good to excellent yields with high stereo- and regioselectivity. Highly substituted and functionalised alkynes have been hydrofluorinated. The method is exploited further to selectively access a fluorinated combretastatin analogue in two steps starting from commercially available reagents, thus further affirming the usefulness of the protocol.

Acknowledgments

The ERC (Advanced Investigator Award FUNCAT and PoC award GOLDCAT), the EPSRC and Syngenta are gratefully acknowledged for support of this work. Umicore AG is acknowledged for their generous gift of auric acid. S.P.N. is a Royal Society Wolfson Research Merit Award holder.

Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/cctc.201402891.

cctc0007-0240-sd1.pdf (4.5MB, pdf)

References

  • [1a].Shimizu M, Hiyama T. Angew. Chem. Int. Ed. 2005;44:214. doi: 10.1002/anie.200460441. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2005;117 [Google Scholar]
  • [1b].Purser S, Moore PR, Swallow S, Gouverneur V. Chem. Soc. Rev. 2008;37:320. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]
  • [2].Müller K, Faeh C, Diederich F. Science. 2007;317:1881. doi: 10.1126/science.1131943. [DOI] [PubMed] [Google Scholar]
  • [3a].Zhang Z, Wang F, Mu X, Chen P, Liu G. Angew. Chem. Int. Ed. 2013;52:7549. doi: 10.1002/anie.201301891. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013;125 [Google Scholar]
  • [3b].Larsson JM, Pathipati SR, Szabo KJ. J. Org. Chem. 2013;78:7330. doi: 10.1021/jo4010074. [DOI] [PubMed] [Google Scholar]
  • [3c].Ye Y, Schimler SD, Hanley PS, Sanford MS. J. Am. Chem. Soc. 2013;135:16292. doi: 10.1021/ja408607r. [DOI] [PubMed] [Google Scholar]
  • [3d].Mu X, Zhang H, Chena P, Liu G. Chem. Sci. 2014;5:275. [Google Scholar]
  • [3e].Truong T, Klimovica K, Daugulis O. J. Am. Chem. Soc. 2013;135:9342. doi: 10.1021/ja4047125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4a].McMurtrey KB, Racowski JM, Sanford MS. Org. Lett. 2012;14:4094. doi: 10.1021/ol301739f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4b].Katcher MH, Doyle AG. J. Am. Chem. Soc. 2010;132:17402. doi: 10.1021/ja109120n. [DOI] [PubMed] [Google Scholar]
  • [4c].Watson DA, Su M, Teverovskiy G, Zhang Y, Garcia-Fortanet J, Kinzel T, Buchwald SL. Science. 2009;325:1661. doi: 10.1126/science.1178239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4d].Lee HG, Milner PJ, Buchwald SL. J. Am. Chem. Soc. 2014;136:3792. doi: 10.1021/ja5009739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4e].Braun MG, Doyle AG. J. Am. Chem. Soc. 2013;135:12990. doi: 10.1021/ja407223g. [DOI] [PubMed] [Google Scholar]
  • [4f].Fier PS, Hartwig JF. J. Am. Chem. Soc. 2012;134:10795. doi: 10.1021/ja304410x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4g].Fier PS, Luo J, Hartwig JF. J. Am. Chem. Soc. 2013;135:2552. doi: 10.1021/ja310909q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5a].Benedetto E, Tredwell M, Hollingworth C, Khotavivattana T, Brown JM, Gouverneur V. Chem. Sci. 2013;4:89. [Google Scholar]
  • [5b].Topczewski JJ, Tewson TJ, Nguyen HM. J. Am. Chem. Soc. 2011;133:19318. doi: 10.1021/ja2087213. [DOI] [PubMed] [Google Scholar]
  • [6].Zhang C, Li Z, Zhu L, Yu L, Wang Z, Li C. J. Am. Chem. Soc. 2013;135:14082. doi: 10.1021/ja408031s. [DOI] [PubMed] [Google Scholar]
  • [7].Zhu J, Tsui GC, Lautens M. Angew. Chem. Int. Ed. 2012;51:12353. doi: 10.1002/anie.201207356. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012;124 [Google Scholar]
  • [8].Liu W, Huang X, Cheng MJ, Nielsen RJ, Goddard 3rd WA, Groves JT. Science. 2012;337:1322. doi: 10.1126/science.1222327. [DOI] [PubMed] [Google Scholar]
  • [9a].Hull KL, Anani WQ, Sanford MS. J. Am. Chem. Soc. 2006;128:7134. doi: 10.1021/ja061943k. [DOI] [PubMed] [Google Scholar]
  • [9b].Prakash GKS, Beier P. Angew. Chem. Int. Ed. 2006;45:2172. doi: 10.1002/anie.200503783. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006;118 [Google Scholar]
  • [9c].Hintermann L, Togni A. Angew. Chem. Int. Ed. 2000;39:4359. doi: 10.1002/1521-3773(20001201)39:23<4359::AID-ANIE4359>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2000;112 [Google Scholar]
  • [9d].Fraser SL, Antipin MY, Khroustalyov VN, Grushin VV. J. Am. Chem. Soc. 1997;119:4769. [Google Scholar]
  • [9e].Barthazy P, Togni A, Mezzetti A. Organometallics. 2001;20:3472. [Google Scholar]
  • [9f].Grushin VV. Angew. Chem. Int. Ed. 1998;37:994. doi: 10.1002/(SICI)1521-3773(19980420)37:7<994::AID-ANIE994>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 1998;110 [Google Scholar]
  • [9g].Liang T, Neumann C, Ritter T. Angew. Chem. Int. Ed. 2013;52:8214. doi: 10.1002/anie.201206566. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013;125 [Google Scholar]
  • [9h].Lee E, Kamlet AS, Powers DC, Neumann CN, Boursalian GB, Furuya T, Choi DC, Hooker JM, Ritter T. Science. 2011;334:639. doi: 10.1126/science.1212625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10a].Akana JA, Bhattacharyya KX, Müller P, Sadighi JP. J. Am. Chem. Soc. 2007;129:7736. doi: 10.1021/ja0723784. [DOI] [PubMed] [Google Scholar]
  • [10b].Laitar DS, Müller P, Gray TG, Sadighi JP. Organometallics. 2005;24:4503. [Google Scholar]
  • [10c].D. S. Laitar, Ph.D. thesis, Massachusetts Institute of Technology, 2006
  • [10d].Gorske BC, Mbofana CT, Miller SJ. Org. Lett. 2009;11:4318. doi: 10.1021/ol9016782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10e].Okoromoba OE, Han J, Hammond GB, Xu B. J. Am. Chem. Soc. 2014;136:14381. doi: 10.1021/ja508369z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11a].Vergote T, Nahra F, Welle A, Luhmer M, Wouters J, Mager N, Riant O, Leyssens T. Chem. Eur. J. 2012;18:793. doi: 10.1002/chem.201102655. [DOI] [PubMed] [Google Scholar]
  • [11b].Vergote T, Nahra F, Peeters D, Riant O, Leyssens T. J. Organomet. Chem. 2013;730:95. [Google Scholar]
  • [11c].Vergote T, Nahra F, Merschaert A, Riant O, Peeters D, Leyssens T. Organometallics. 2014;33:1953. [Google Scholar]
  • [12].Liu Y, Chen C, Li H, Huang K-W, Tan J, Weng Z. Organometallics. 2013;32:6587. [Google Scholar]
  • [13].Coulson DR. J. Am. Chem. Soc. 1976;98:3111. [Google Scholar]
  • [14a].Ball ND, Sanford MS. J. Am. Chem. Soc. 2009;131:3796. doi: 10.1021/ja8054595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14b].Dubinsky-Davidchik IS, Goldberg I, Vigalok A, Vedernikov AN. Chem. Commun. 2013;49:3446. doi: 10.1039/c3cc41079j. [DOI] [PubMed] [Google Scholar]
  • [14c].Jasim NA, Perutz RN. J. Am. Chem. Soc. 2000;122:8685. [Google Scholar]
  • [14d].Whittlesey MK, Perutz RN, Greener B, Moore MH. Chem. Commun. 1997:187. [Google Scholar]
  • [14e].Kirkham MS, Mahon MF, Whittlesey MK. Chem. Commun. 2001:813. [Google Scholar]
  • [14f].Marshall WJ, Grushin VV. Organometallics. 2004;23:3343. [Google Scholar]
  • [14g].Macgregor SA, Roe DC, Marshall WJ, Bloch KM, Bakhmutov VI, Grushin VV. J. Am. Chem. Soc. 2005;127:15304. doi: 10.1021/ja054506z. [DOI] [PubMed] [Google Scholar]
  • [14h].Murphy VJ, Hascall T, Chen JY, Parkin G. J. Am. Chem. Soc. 1996;118:7428. [Google Scholar]
  • [14i].Segarra C, Mas-Marzá E, Lowe JP, Mahon MF, Poulten RC, Whittlesey MK. Organometallics. 2012;31:8584. [Google Scholar]
  • [14j].Vicente J, Gil-Rubio J, Bautista D, Sironi A, Masciocchi N. Inorg. Chem. 2004;43:5665. doi: 10.1021/ic049585e. [DOI] [PubMed] [Google Scholar]
  • [14k].Braun T, Foxon SP, Perutz RN, Walton PH. Angew. Chem. Int. Ed. 1999;38:3326. doi: 10.1002/(sici)1521-3773(19991115)38:22<3326::aid-anie3326>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 1999;111 [Google Scholar]
  • [14l].B. Truscott, F. Nahra, A. M. Z. Slawin, D. B. Cordes, S. P. Nolan, Chem. Commun2014. ­, DOI: [DOI] [PubMed]
  • [15].Bramananthan N, Carmona M, Lowe JP, Mahon MF, Poulten RC, Whittlesey MK. Organometallics. 2014;33:1986. [Google Scholar]
  • [16].Nahra F, Patrick SR, Collado A, Nolan SP. Polyhedron. 2014;84:59. [Google Scholar]
  • [17].For syntheses of Se(NHC) complexes and examples of their coordination to gold, see: Nelson DJ, Nahra F, Patrick SR, Cordes DB, Slawin AMZ, Nolan SP. Organometallics. 2014;33:3640. [Google Scholar]
  • [18a].This phenomenon has been observed previously with Cu(NHC) bifluorides with similar structures, see Ref. [11a]for more details;
  • [18b].for X-ray structures and analyses of 4 a5. (CCDC 1023541) and (CCDC 1023542), see the Supporting Information (these data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif )
  • [19].This result correlates with the same procedure used to access the [Au(SIPr)F] complex starting from [Au(SIPr)(Ot. Bu)] reported by Sadighi, Gray and co-workers (see Ref. [10b])
  • [20].Complex 2 a11933⋅3⋅3119. was reacted with 1 equivalent of KOH under Ar in a NMR tube and then monitored by using H and F NMR. Complex  was reacted with 1.1 equivalent of NEt 2 HF (prepared by diluting NEt 3 HF with NEt ) under Ar in a NMR tube and also monitored by using H and F NMR.
  • [21a].For AgF hydrofluorination, see: Li Y, Liu X, Ma D, Liu B, Jiang H. Adv. Synth. Catal. 2012;354:2683. . For other Au-catalysed fluorination reactions, see: [Google Scholar]
  • [21b].Wang W, Jasinski J, Hammond GB, Xu B. Angew. Chem. Int. Ed. 2010;49:7247. doi: 10.1002/anie.201003593. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2010;122 [Google Scholar]
  • [21c].Schuler M, Silva F, Bobbio C, Tessier A, Gouverneur V. Angew. Chem. Int. Ed. 2008;47:7927. doi: 10.1002/anie.200802162. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120 [Google Scholar]
  • [21d].Mankad NP, Toste FD. Chem. Sci. 2012;3:72. doi: 10.1039/C1SC00515D. ; For other hydrofluorination of alkenes processes, see: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21e].Barker TJ, Boger DL. J. Am. Chem. Soc. 2012;134:13588. doi: 10.1021/ja3063716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21f].Shigehisa H, Nishi E, Fujisawa M, Hiroya K. Org. Lett. 2013;15:5158. doi: 10.1021/ol402696h. [DOI] [PubMed] [Google Scholar]
  • [21g].Emer E, Pfeifer L, Brown JM, Gouverneur V. Angew. Chem. 2014;126:4265. doi: 10.1002/anie.201310056. [DOI] [PubMed] [Google Scholar]
  • [22].AgF has been used stoichiometrically to hydrofluorinate bromo-, iodo-, and one chloro-phenylacetylene derivatives, however no catalytic procedure has been reported; see Ref. [21a]
  • [23].Park K, Bae G, Moon J, Choe J, Song KH, Lee S. J. Org. Chem. 2010;75:6244. doi: 10.1021/jo101398a. ; see the Supporting Information for synthesis details. [DOI] [PubMed] [Google Scholar]
  • [24].Combretastatin A4 is a known anti-cancer drug; for synthesis and biological activity of fluorinated combretastatin analogues, see: Alloatti D, Giannini G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi MB, Carminati P, Pisano C. J. Med. Chem. 2008;51:2708. doi: 10.1021/jm701362m. [DOI] [PubMed] [Google Scholar]
  • [25].Due to low conversion and similar polarity of starting material and both regioisomers of the final product, we were only able to isolate the major regioisomer contaminated with small amounts of the starting material and a corrected isolated yield of 32 % was obtained
  • [26].D. Bello, R. A. Cormanich, D. O’Hagan, Aust. J. Chem2014. ­, in press, DOI:
  • [27].Elevated temperatures were avoided due to the observed formation of multiple product isomers and the thermal instability of some substrates. This instability could even affect yields at room temperature, as starting materials and products may have partially decomposed during the course of the reaction or work-up. In these cases, NH44. BF did not have a beneficial effect and was therefore removed.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

cctc0007-0240-sd1.pdf (4.5MB, pdf)

Articles from Chemcatchem are provided here courtesy of Wiley

RESOURCES